UUID: 7934CD2D- A310 “FC- ABFI- 3A21CE2RE3e286ac
TCGA- 26- AAKL- 01A- PR

ill till?"“"l'l'i'liili'lllili..lilil' illitlilt'im

 

‘ 12;?6“3Mm5 92,7015
51:: Q) Jun/Vb Cite-2,97
gm 614/",

Concerning

Summary pathology report

Left orchidectorny; nonseminoma (EC 90%, MT + IT 5%. YST 5%, trophoblastic giant cells);
diameter 3 cm; angio-invasion present; invasion of rete testis present; tumor conﬁned to testis.

Date of procurement (= date of orchidectomy):

pathologist

professor of pathology

ppm} ﬂ! (#1 wow /
ﬂex} ,‘5 IﬂzW fun

1&3

Tumor Sire
HlFAA

case is
Initials

 

 

 

v4.90
TCGA Pathologic Diagnosis Discrepancy Form

 

 

 

 

 

 

instructions; The TCGA Pathologic Diagnosis Discrepancy Form should be completed when the pathologic diagnosis

documented on the initial pathology report for a case submitted for TCGA is inconsistent with the diagnosis provided on the
Case Quality Control Form completed for the submitted case.

 

 

 

 

 

 

 

Tissue Source Site (T 58): ___________TSS identiﬁer: TSS Unique Patient Identiﬁer:
Completed By (Interviewer Name _C ompleted Date: _
Diagnosis Information
# Data Element Entry Alternatives Working Instructions
EC (90%) MT plus IT (5%) YST (5 3;) Provide the diagnosis/ histologic subtype(s) documented on
Pathologic Diagnosis I I the initial pathology report for this case. If the histology for
1 Provided on Initial ——-——————— this case is mixed, provide all listed subtypes.
PathOIOgy Report
. . EC ( 1 o O a; ) Provide the histologic features selected on the TCGA Case
H‘StOIOglc features 0f Quality Control Form completed for this case.
2 the sample provtded
for TCGA, as reﬂected
on the CQCF.

 

 

 

 

Discrepancy between Pathology Report and Case Quality Control Form

 

 

 

3 Provide the reascn for Due to the histological heterogeneous Provide a reason describing why the diagnosis on the initial
thediscrepancv 0f Sigiszaiszzttri‘i:izzrsssecaazistritiizm
between the pathology representation of the different
report and the TCGA elements can and is in fact expected
Case Quality CONTOI to differ between the FFPE and frozen
Form. samples of the same case.

However , the components are monoclonal
in origin.
Name of TSS Reviewing Provide the name of the pathologist who reviewed this case

4 Pathologist or _ for TCGA‘

Biorepository Director

 

 

 

 

 

I acknowledge that the above information provided by my institution is true and correct and has been quality controlled.

 

 

TSS Reviewing Pathologist or Biorepository Director Date

I acknowledge that the above information provided by my institution is true and correct and has been quality controlled. TheAttending Pathologist or the
Department Chairman has been informed or is aware of the above discrepancy in diagnoses.

 

Principal Investigator Signature Date

 

